Auransa
Auransa is a clinical-stage, AI-native biopharma company focused on discovering novel therapeutics and improving cancer care. Their proprietary AI platform analyzes vast amounts of human disease data to identify drug candidates for the most responsive patients. The company leverages its AI platform to advance drug discovery programs, aiming to address the needs of cancer patients. Auransa collaborates with leading pharmaceutical companies and academic institutions to bring these programs to market. Their lead program, AU-409, is currently in a Phase 1 clinical trial for liver cancer.
Auransa
Auransa is a clinical-stage, AI-native biopharma company focused on discovering novel therapeutics and improving cancer care. Their proprietary AI platform analyzes vast amounts of human disease data to identify drug candidates for the most responsive patients. The company leverages its AI platform to advance drug discovery programs, aiming to address the needs of cancer patients. Auransa collaborates with leading pharmaceutical companies and academic institutions to bring these programs to market. Their lead program, AU-409, is currently in a Phase 1 clinical trial for liver cancer.